Layer 2/3 pyramidal cells in the medial prefrontal cortex moderate stress induced depressive behaviors

Prerana Shrestha1, Awni Mousa1, Nathaniel Heintz1

  • 1Laboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, United States.

Elife
|September 16, 2015
PubMed

Insights

Wfs1 gene deletion in medial prefrontal cortex layer 2/3 pyramidal cells impairs stress resilience. This dysfunction contributes to major depressive disorder (MDD) by affecting the stress response and neurotrophic factors.

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Major depressive disorder (MDD) is a common mental illness often triggered by stress.
  • Wfs1 gene mutations are linked to MDD in Wolfram syndrome patients.
  • The medial prefrontal cortex (mPFC) plays a role in depression and resilience, but specific cell types involved are unclear.

Purpose of the Study:

  • To investigate the role of Wfs1 in medial prefrontal cortex (mPFC) layer 2/3 pyramidal cells in stress-induced depressive behaviors.
  • To identify specific mPFC cell types and circuits that moderate depressive behaviors in response to stress.

Main Methods:

  • Utilized genetic deletion of Wfs1 in layer 2/3 pyramidal cells of the mPFC.
  • Assessed stress-induced depressive behaviors.
  • Measured hypothalamic-pituitary-adrenal (HPA) axis activity.
  • Analyzed the accumulation of growth and neurotrophic factors.

Main Results:

  • Deletion of Wfs1 in mPFC layer 2/3 pyramidal cells impaired the suppression of stress-induced depressive behaviors.
  • This genetic alteration led to hyperactivation of the HPA axis.
  • Altered accumulation of key growth and neurotrophic factors was observed.

Conclusions:

  • Superficial layer 2/3 pyramidal cells in the mPFC are critical for moderating stress responses in the context of depressive behaviors.
  • Wfs1 dysfunction in these specific cells may underlie the connection between stress and depression.
  • These findings offer potential therapeutic targets for MDD.